Delivery Order SPE2DB24D2212-SPE2DB25FHPQL

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets, a medication used to treat hypertension. The contract has a ceiling value of $1,094.27 and an ultimate completion date of August 26, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,455.71, is for the delivery of 90 tablets of Olmesartan Medoxomil 40 mg, a blood pressure medication. The contract has a completion date of February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.58, is for the delivery of Olmesartan Medoxomil 40 mg tablets in 90-count packages. The contract type is firm fixed price, and the ultimate completion date is February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olmesartan Medoxomil 40 mg tablets in 90-count packages, with a ceiling value of $5,672.29. It is a firm-fixed-price contract with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,877.34, is for the supply of Olmesartan Medoxomil 40 mg tablets in 30-count packages. The contract has a period of performance through January 3, 2025 and utilizes a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olmesartan Medoxomil 40 mg tablets in 90-count packages, with a ceiling value of $6,984.78 and a performance period ending on January 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has a ceiling value of $2,275.38 and a completion date of February 7, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets in 90-count packages, with a ceiling value of $7,189.33 and a period of performance through April 2025. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,826.72 firm fixed-price contract is for the delivery of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of November 16, 2023 and was awarded on November 15, 2023. This contract is part of a larger $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication, with a ceiling value of $9,824.93 and a period of performance through January 17, 2024. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHPQL
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets, a medication used to treat high blood pressure. The contract has a ceiling value of $3,587.68 and is a firm fixed-price contract. The period of performance extends through April 30, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/29/25, 9:50 AM